Aciclovir Sandoz cream

Aciclovir Sandoz is a generic antiviral topical treatment used primarily for the management of viral skin infections such as herpes labiale (cold sores) and herpes genitale. The specific packaging shown identifies the product as 'Aciclovir Sandoz 3g crema 5%', intended for the Italian market as indicated by the Italian text ('Medicinale non soggetto a prescrizione medica') and the presence of the Italian AIC code (033731047).

The Sandoz brand has a deep-rooted history, founded in 1886 in Basel, Switzerland, by Edouard-Constant Sandoz and Alfred Kern. While it spent several decades as the generic and biosimilars division of the global pharmaceutical giant Novartis, Sandoz underwent a significant transformation in October 2023. It was successfully spun off as a fully independent, standalone company listed on the SIX Swiss Exchange. As of 2026, Sandoz Group AG operates as a global leader in its own right, headquartered in Basel, Switzerland. The product shown is distributed and held in Italy by Sandoz S.p.A., based in Origgio (Varese).